Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,803 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Endoscopic evaluation after surgery in inflammatory bowel disease - Authors' reply.
Shen B, Bortlik M, Bruining DH, Coelho-Prabhu N, El-Hachem S, Farraye FA, Iacucci M, Kobayashi T, Kochhar GS, Kotze PG, Lama YG, Levy AN, Liu X, Mao R, Navaneethan U, Schwartz DA, Shergill A, Sood A, Suárez BG. Shen B, et al. Among authors: mao r. Lancet Gastroenterol Hepatol. 2021 Sep;6(9):691-692. doi: 10.1016/S2468-1253(21)00255-7. Lancet Gastroenterol Hepatol. 2021. PMID: 34391522 No abstract available.
Effects of Combination Therapy With Immunomodulators on Trough Levels and Antibodies Against Tumor Necrosis Factor Antagonists in Patients With Inflammatory Bowel Disease: A Meta-analysis.
Qiu Y, Mao R, Chen BL, Zhang SH, Guo J, He Y, Zeng ZR, Ben-Horin S, Chen MH. Qiu Y, et al. Among authors: mao r. Clin Gastroenterol Hepatol. 2017 Sep;15(9):1359-1372.e6. doi: 10.1016/j.cgh.2017.02.005. Epub 2017 Feb 14. Clin Gastroenterol Hepatol. 2017. PMID: 28232073 Review.
Association of Vedolizumab Level, Anti-Drug Antibodies, and α4β7 Occupancy With Response in Patients With Inflammatory Bowel Diseases.
Ungar B, Kopylov U, Yavzori M, Fudim E, Picard O, Lahat A, Coscas D, Waterman M, Haj-Natour O, Orbach-Zingboim N, Mao R, Chen M, Chowers Y, Eliakim R, Ben-Horin S. Ungar B, et al. Among authors: mao r. Clin Gastroenterol Hepatol. 2018 May;16(5):697-705.e7. doi: 10.1016/j.cgh.2017.11.050. Epub 2017 Dec 7. Clin Gastroenterol Hepatol. 2018. PMID: 29223444
Role of interventional inflammatory bowel disease in the era of biologic therapy: a position statement from the Global Interventional IBD Group.
Shen B, Kochhar G, Navaneethan U, Liu X, Farraye FA, Gonzalez-Lama Y, Bruining D, Pardi DS, Lukas M, Bortlik M, Wu K, Sood A, Schwartz DA, Sandborn WJ; Global Interventional Inflammatory Bowel Disease Group. Shen B, et al. Gastrointest Endosc. 2019 Feb;89(2):215-237. doi: 10.1016/j.gie.2018.09.045. Epub 2018 Oct 24. Gastrointest Endosc. 2019. PMID: 30365985 Review.
Efficacy of biological drugs in short-duration versus long-duration inflammatory bowel disease: a protocol for a systematic review and an individual-patient level meta-analysis of randomised controlled trials.
Ben-Horin S, Zhao Y, Guo J, Mao R, Novack L, Sergienko R, Zhang J, Kobayashi T, Hibi T, Chowers Y, Colombel JF, Peyrin-Biroulet L, Kaplan G, Chen MH. Ben-Horin S, et al. Among authors: mao r. BMJ Open. 2019 Jan 25;9(1):e024222. doi: 10.1136/bmjopen-2018-024222. BMJ Open. 2019. PMID: 30782731 Free PMC article.
Histopathology Scoring Systems of Stenosis Associated With Small Bowel Crohn's Disease: A Systematic Review.
Gordon IO, Bettenworth D, Bokemeyer A, Srivastava A, Rosty C, de Hertogh G, Robert ME, Valasek MA, Mao R, Kurada S, Harpaz N, Borralho P, Pai RK, Pai RK, Odze R, Feakins R, Parker CE, Nguyen T, Jairath V, Baker ME, Bruining DH, Fletcher JG, Feagan BG, Rieder F; Stenosis Therapy and Anti-Fibrotic Research (STAR) Consortium. Gordon IO, et al. Among authors: mao r. Gastroenterology. 2020 Jan;158(1):137-150.e1. doi: 10.1053/j.gastro.2019.08.033. Epub 2019 Aug 30. Gastroenterology. 2020. PMID: 31476299 Free PMC article.
1,803 results